A novel sarsasapogenin glycoside from Asparagus racemosus elicits protective immune responses against HBsAg

Immunology Letters

Volumn 135, Issue 1-2, 2011, Pages 129-135

  Sidiq, Tabasum ^a   Khajuria, Anamika ^a   Suden, Pankaj ^a   Singh, Surjeet ^a   Satti, N K ^a   Suri, K A ^a   Srinivas, V K ^b   Krishna, E ^b   Johri, R K ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

^b Bharat Biotech International   (India)

Author keywords

Asparagus racemosus; Cytokines; Immunoside; Macrophages; Splenocytes; Th1 Th2 response

Indexed keywords

ALUMINUM POTASSIUM SULFATE; CD19 ANTIGEN; GAMMA INTERFERON; GLYCOSIDE; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOSIDE; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; NITRITE; SARSASAPOGENIN; SARSASAPOGENIN GLYCOSIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; ASPARAGUS; ASPARAGUS RACEMOSUS; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; DRUG STRUCTURE; FEMALE; HEMOLYSIS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION; TH1 CELL; TH2 CELL; TOXICITY TESTING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; ASPARAGUS PLANT; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GLYCOSIDES; HEPATITIS B SURFACE ANTIGENS; MICE; MICE, INBRED BALB C; SPIROSTANS; TH1 CELLS; TH2 CELLS;

EID: 78751703436     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2010.10.013     Document Type: Article

References (25)

1. Ingolotti M., Kawalekar O., Shedlock D.J., Muthumani K., Weiner D.B. DNA vaccines for targeting bacterial infections. Exp Rev Vacc 2010, 9:747-763.
2. Gupta R.K., Rost B.E., Relyveld E., Siber G.R. Adjuvant properties of aluminium and calcium compounds. Vaccine design: the subunit and adjuvant approach 1995, 229-248. Plenum Press, New York, USA. M.F. Powell, M.J. Newman (Eds.).
3. Moingeon P. Strategies for designing vaccines eliciting Th1 responses in humans. J Biotechnol 2002, 98:189-198.
4. Bopana N., Saxena S. Asparagus racemosus - ethnopharmacological evaluation and conservation needs. J Ethnopharmacol 2007, 110:1-15.
5. Rege N.N., Nazareth H.M., Isaac A.A., Karandikar S.M., Dahanukar S.A. Immunotherapeutic modulation of intraperitoneal adhesions by Asparagus racemosus. J Postgr Med 1989, 35:199-203.
6. Gautam M., Diwanay S., Gairola S., Shinde Y., Patki P., Patwardhan B. Immunoadjuvant potential of Asparagus racemosus aqueous extract in experimental system. J Ethnopharmacol 2004, 91:251-255.
7. Satti N.K., Suri K.A., Dutt P., Suri O.P., Amina M., Qazi G.N., et al. Evaluation of Asparagus racemosus on the basis of immunomodulating sarsasapogenin glycosides by HPTLC. J Liq Chromatogr 2006, 29:219-227.
8. Handa SS, Suri OP, Gupta VN, Suri KA, Naresh KB. Process for the isolation of novel oligostanoside. US Pat: 6, 670,459; 30 December 2003.
9. Jaganathan K.S., Vyas S.P. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant Hepatitis B antigen administered intranasally. Vaccine 2006, 24:4201-4211.
10. Khajuria A., Gupta A., Malik F., Singh S., Singh J., Gupta B.D., et al. A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg. Vaccine 2007, 25:4586-4594.
11. Malik F., Singh J., Khajuria A., Suri K.A., Satti N.K., Singh S., et al. A standarized root extract of Withania somnifera and its major constituent withanolide-A elicit humoral and cell-mediated immune responses by up regulation of Th1-dominant polarization in BALB/c mice. Life Sci 2007, 80:1525-1538.
12. Assenmacher M., Schmitz J., Radbruch A. Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-gamma and in interleukin-4-expressing cells. Eur J Immunol 1994, 24:1097-1101.
13. 15N] nitrate in biological fluids. Anal Biochem 1982, 126:131-138.
14. Kensil C.R., Kammer R. QS-21: a water soluble triterpene glycoside adjuvant. Exp Opin Invest Drugs 1998, 7:1475-1482.
15. Geissler M., Tokushige K., Chante C.C., Zurawski V.R., Wands J.R. Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization. Gastroenterology 1997, 112:1307-1320.
16. Schirmbeck R., Zheng X., Roggendorf M., Geissler M., Chisari F.V., Reimann J., et al. Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen. J Immunol 2001, 166:1405-1413.
17. Wheeler A.W., Woroniecki S.R. Immunological adjuvants in allergy vaccines: past, present and future. Allergy Int 2001, 50:295-301.
18. Kovarik J., Siegrist A.C. Optimization of vaccine responses in early life: the role of delivery systems and immunomodulators. Immunol Cell Biol 1998, 76:222-236.
19. Coffman R.L., Seymour B.W.P., Lebman D.A., Hiraki D.D., Christiansen J.A., Shrader B., et al. The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev 1988, 102:5-28.
20. Seghal P.B., May L.T., Tamm I., Vilcek J. Human β2-interferon and B cell differentiation factor BSF-2 are identical. Science 1987, 235:731-732.
21. Peters M. Actions of cytokines on the immune response and viral interactions: an overview. Hepatology 1996, 23:909-916.
22. Kaiko G.E., Horvat J.C., Beagley K.W., Hansbro P.M. Immunological decision-making: how does the immune system decide to mount a helper T-cell response?. J Immunol 2008, 123:326-338.
23. Fletcher M., Goldstein A.L. Recent advances in the understanding of the biochemistry and clinical pharmacology of interleukin-2. Lymphokine Res 1987, 6:45-57.
24. Laskin D.L., Pendino K.J. Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol 1995, 35:655-677.
25. Guidotti L.G., McClary H., Loudis J.M., Chisari F.V. Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice. J Exp Med 2000, 191:1247-1252.